Literature DB >> 33361146

Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes.

Louis Potier1,2, Boris Hansel1,2, Etienne Larger3, Jean-François Gautier2,4, Daphné Carreira1,5, Rachel Assemien1,5, Olivier Lantieri1,6, Jean-Pierre Riveline2,4, Ronan Roussel7,2.   

Abstract

OBJECTIVE: To investigate the impact of coronavirus disease 2019 lockdown on glycemic control and associated factors in people living with type 1 diabetes. RESEARCH DESIGN AND METHODS: An observational evaluation from a self-reported questionnaire on behavioral changes and glycemic information from flash glucose monitoring (FGM) during the lockdown in 1,378 individuals living with type 1 diabetes who used a French dedicated nationwide web application (CoviDIAB).
RESULTS: The main outcome was the change of the mean glucose level 2 months before and 1 month after the lockdown. We found that mean glucose improved from 9.1 ± 1.7 mmol/L to 8.7 ± 1.7 mmol/L (P < 0.001). Factors associated with better glycemic control were a decrease of alcohol consumption (odds ratio [OR] 1.75 [95% CI 1.04-2.94]), an increase in the frequency of FGM scans (OR 1.48 [1.04-2.10]) and in the number of hypoglycemia events (OR 1.67 [1.13-2.46]), and an easier diabetes control perception (OR 1.71 [1.18-2.49]).
CONCLUSIONS: Our findings suggest that lockdown has a positive impact on glycemic control in people with type 1 diabetes.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 33361146     DOI: 10.2337/dc20-2019

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.

Authors:  Tara Kaushal; Liane J Tinsley; Lisa K Volkening; Christine Turcotte; Lori M Laffel
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 2.  Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.

Authors:  Saula Vigili de Kreutzenberg
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-05-17

3.  Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic.

Authors:  Tara Kaushal; Liane Tinsley; Lisa K Volkening; Louise Ambler-Osborn; Lori Laffel
Journal:  Diabetes Technol Ther       Date:  2021-10-13       Impact factor: 6.118

4.  Glycaemic control during the COVID-19 pandemic: A catastrophe or a sign of hope for the person with type 1 Diabetes Mellitus?

Authors:  Diogo Ramalho; Ana Rouxinol-Dias; Patrícia Tavares; Sara Correia; Lúcia Almeida; Helena Alves; Gustavo Rocha; Maria João Oliveira
Journal:  Endocrinol Diabetes Nutr       Date:  2022-01-31

5.  Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.

Authors:  Pietro Lazzeroni; Matteo Motta; Sara Monaco; Serena Rosa Laudisio; Daria Furoncoli; Valentina Maffini; Monica Rubini; Bertrand Tchana; Claudio Ruberto; Icilio Dodi; Brunella Iovane
Journal:  Acta Biomed       Date:  2021-11-03

6.  Experiences and actions related to living with type 1 diabetes during the COVID-19 pandemic in Norway: a qualitative study conducted during July to December 2020.

Authors:  Karin Pleym; Marjolein Memelink Iversen; Anders Broström
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

7.  Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Ifan Ali Wafa; Nando Reza Pratama; Nurizzah Farahiyah Sofia; Elsha Stephanie Anastasia; Tiffany Konstantin; Maharani Ayuputeri Wijaya; M Rifqi Wiyono; Lilik Djuari; Hermina Novida
Journal:  Diabetes Metab J       Date:  2022-03-08       Impact factor: 5.376

Review 8.  Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.

Authors:  Thomas Danne; Catarina Limbert; Manel Puig Domingo; Stefano Del Prato; Eric Renard; Pratik Choudhary; Alexander Seibold
Journal:  Diabetes Ther       Date:  2021-08-02       Impact factor: 2.945

Review 9.  Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.

Authors:  Monia Garofolo; Michele Aragona; Cosimo Rodia; Pierpaolo Falcetta; Alessandra Bertolotto; Fabrizio Campi; Stefano Del Prato; Giuseppe Penno
Journal:  Diabetes Res Clin Pract       Date:  2021-09-23       Impact factor: 5.602

10.  The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes.

Authors:  Nicola Minuto; Marta Bassi; Carolina Montobbio; Francesco Vinci; Claudia Mercuri; Francesca Nastasia Perri; Mara Cabri; Maria Grazia Calevo; Giuseppe d'Annunzio; Mohamad Maghnie
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.